N14.1 Nephropathy induced by other drugs, medicaments and biological substances

Name of the Condition

• Nephropathy induced by other drugs, medicaments and biological substances
• ICD-10 Code: N14.1

Summary

Nephropathy induced by other drugs, medicaments and biological substances refers to kidney damage caused by exposure to substances other than those classified under more specific drug-induced nephropathy codes. This condition involves structural or functional impairment of the kidneys resulting from the toxic, allergic, or metabolic effects of medications, biologics, or other therapeutic agents. The severity and reversibility depend on the substance involved, duration of exposure, and timely intervention.

Causes

Kidney damage in this category arises from the direct or indirect effects of drugs, medicaments, or biological substances that are not categorized under more specific nephropathy codes. Common culprits include certain antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), chemotherapeutic agents, contrast media, or biologics. The mechanism may involve tubular toxicity, interstitial inflammation, glomerular injury, or vascular damage. In some cases, the nephropathy is dose-dependent, while in others, it may result from idiosyncratic reactions.

Risk Factors

• Medication use: Prolonged or high-dose exposure to nephrotoxic drugs.
• Pre-existing kidney disease: Reduced renal reserve increases susceptibility.
• Age: Elderly patients may have decreased drug clearance.
• Dehydration or hypovolemia: Worsens renal perfusion and drug toxicity.
• Combination therapy: Use of multiple nephrotoxic agents simultaneously.

Symptoms

• Reduced urine output or oliguria.
• Swelling in the legs, ankles, or around the eyes.
• Fatigue, nausea, or loss of appetite.
• Elevated blood pressure.
• Dark, cloudy, or foamy urine (indicating protein or blood).
• Unexplained weight gain from fluid retention.

Diagnosis

Diagnosis requires a thorough patient history focusing on recent or ongoing medication use, including over-the-counter drugs, supplements, or biologics. Laboratory tests assess kidney function (e.g., serum creatinine, blood urea nitrogen) and detect abnormalities like proteinuria or hematuria. Imaging (e.g., ultrasound) may evaluate kidney structure, while renal biopsy is sometimes used to confirm the type of injury (e.g., interstitial nephritis, tubular necrosis). Discontinuation of the suspected agent and monitoring for improvement support the diagnosis.

Treatment Options

Treatment centers on discontinuing the offending substance and managing symptoms. Supportive care includes maintaining hydration, correcting electrolyte imbalances, and controlling blood pressure. In severe cases, dialysis may be necessary to support kidney function temporarily. Corticosteroids or other immunosuppressants are used if an allergic or inflammatory component is suspected. Long-term monitoring ensures recovery and prevents recurrence.

Prognosis and Follow-Up

Prognosis varies based on the substance, duration of exposure, and extent of kidney damage. Early intervention often leads to partial or full recovery, but some cases may result in chronic kidney disease. Follow-up includes regular monitoring of kidney function and blood pressure. Patients are advised to avoid re-exposure to the causative agent and to inform healthcare providers of any medication allergies or sensitivities.

Complications

• Acute kidney injury requiring dialysis.
• Progression to chronic kidney disease.
• Electrolyte imbalances (e.g., hyperkalemia).
• Hypertension resistant to treatment.
• Increased risk of infections due to immunosuppression (if steroids are used).

Lifestyle & Prevention

• Medication awareness: Review all drugs (prescription, OTC, supplements) with a provider to identify nephrotoxic risks.
• Hydration: Maintain adequate fluid intake, especially when taking medications known to affect kidneys.
• Monitoring: Regular kidney function tests for patients on long-term nephrotoxic therapies.
• Avoidance: Steer clear of known nephrotoxic substances when possible, or use them under close supervision.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden swelling, reduced urine output, severe fatigue, or unexplained weight gain after starting a new medication. Contact a healthcare provider for persistent symptoms like blood in urine, nausea, or elevated blood pressure, especially if you are taking drugs known to affect kidney function.

Tips for Medical Coders

Document the specific drug, medicament, or biological substance causing the nephropathy, as this supports accurate coding and clinical correlation. Include details on timing (e.g., onset after exposure), reversibility, and any interventions (e.g., discontinuation, dialysis). Ensure the code aligns with the clinical scenario and avoid using this code if a more specific drug-induced nephropathy code applies.